NATCA Bookshelf

75 cooperate in the Employer's approved drug testing program shall be subject to appropriate disciplinary or adverse action. Section 11. Test Procedures a. The Department of Health and Human Services (HHS) Guidelines for Chain of Custody will be utilized for a ll specimen transport and testing. b. The donor shall urinate into either a specimen bottle or specimen container. The collection site person, in the presence of the donor, after determining specimen temperature, pours the urine into two specimen b ottles or containers that are labeled Bottle A and Bottle B or, if Bottle A was used to collect the specimen, pours an appropriate amount into Bottle B. c. The collection site shall send the split specimens (Bottle A and Bottle B) at the same time to the laboratory that will be testing the Bottle A specimen. d. If the test of the first specimen (Bottle A) is verified positive by the Medical Reviewing Officer (MRO), the MRO shall report the results to the Employer's DPC (Drug Program Coordina tor) who will notify the BUE of the test results. The donor may within 72 hours, request that the second specimen (Bottle B) be tested. The Employer will utilize a different HHS certified laboratory for testing the second specimen (Bottle B). All cost as sociated with the testing of the 2 nd sample (Bottle B) shall be borne by the BUE (donor) making the request. e. If the result of the test on the split specimen fails to reconfirm the verified positive result for the primary specimen, the MRO shall v oid the primary test result and the donor shall reenter the group subject to random testing as if the test had not been conducted. Section 12. BUEs shall not be required to disclose the legitimate use of a specific drug at the time of collection, but w ill have an opportunity to provide documentation to the MRO supporting legitimate usage upon a positive test result. A BUE who is found to test positive shall be allowed to provide supplementary evidence to the Employer. Any expense incurred in obtaining such supplementary evidence will be borne by the BUE. Section 13. BUEs who test positive may be temporarily reassigned or detailed to other duties, placed on administrative leave, or indefinitely suspended pending the outcome of any further investigatio n and/or decision on any proposed disciplinary or adverse action. Decisions to reassign/detail, place on administrative leave or indefinitely suspend, will be made on a case - by - case basis depending on several factors including, but not limited to: nature of duties, assessment of safety or security risk, availability of other positions, qualifications of the BUE, etc. Section 14. Test results shall be delivered to the employee by U.S. Mail to the employee's home address of record as soon as practical aft er the specimen has been analyzed. Positive reports shall contain the assigned specimen number, the laboratory address, and the results of the test.

• Cover